Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Nel ASA: Closes agreements related to Everfuel and signs sales and service agreement

(Oslo, 16 August 2019) Nel ASA (OSE: NEL) announced today the closing of the agreements related to the ownership structure in Everfuel Europe A/S (Everfuel), including the signing of an exclusive equipment sales and service agreement. Everfuel will provide a complete offering of hydrogen fuel to heavy duty customers such as city buses (reference is made to the announcement 3 June 2019). As an owner/operator of electrolyzers and fueling stations, Everfuel will vertical integrate the hydrogen value chain to reduce the total cost for the end customer. As an example, bus operators in Europe

Episurf Medical reaches new milestones in its patient population

Episurf Medical (Nasdaq: EPIS B) today announces that the company has reached new milestones in its patient population as more than 100 Episealer® patients now have had their knee implants for more than 3 years, and more than 200 patients have had the implants for more than 2 years. A few months ago, the company announced that 500 patients had been treated with the Episealer® knee implant. The company now reports increasing patient populations in the important 2 and 3-year follow-up periods. A significant part of the patients treated, especially among the first patients which were

Subscription for shares in the subsequent offering by primary insiders

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Reference is made to the subsequent offering (the “Subsequent Offering”) in Norwegian Energy Company ASA (the “Company”) as previously announced, latest on 12 August 2019. Lars Purlund, board member of the Company, has on 15 August 2019 subscribed for 1,982

NextCell Pharma files another patent application

NextCell Pharma AB ("NextCell") today announces that they have filed a new patent application to the Swedish Patent and Registration Office. The patent relates to the Company's proprietary selection algorithm, now with extended and tailored analyses for diseases and conditions affecting the central nervous system.The application was submitted to the Swedish Patent and Registration Agency on August 15 and is formulated to cover the general production of all types of mesenchymal stem cell products derived from multiple donors and cells selected by the selection algorithm. Furthermore, the

XMReality AB (publ), Interim Report, April–June 2019

XMReality delivered sales growth of 37 percent for the second quarter of the year compared with the previous year and strong improvement in the gross margin to 87 (59) percent. Change was successfully implemented during the period in line with its strategy to increase subscription revenue.The quarter: April–June 2019 · Net sales increased by 37 percent to SEK 2,993 thousand (2,186) · Costs totaled SEK -11,997 thousand (-11,620) · The net loss was SEK -7,585 thousand (-7 817). · Net cash used in the period was SEK -4,233 thousand (-8,333) and the equity/assets ratio at the end

INVISIO Interim Report January–June 2019: The strongest quarter so far

CEO comment”Order intake, sales and results in the second quarter are the highest so far and are largely attributable to the order worth SEK 111 million from the new customer USSOCOM (United States Special Operations Command). INVISIO also received a strategic break­through order from the German police, which is an important reference for addressing future customers in the police and security market. After the end of the period, the U.S. Marine Corps selected INVISIO for their Hearing Enhancement Program and placed an initial order of SEK 43 million. The positive performance, along with a

Interim report January-June 2019

Total return on the Bure share was 47.9 per centJanuary – June 2019 · Net asset value was SEK 153.5 per share compared to SEK 137.1 at the beginning of the year, which corresponds to an increase of 12.0 per cent. · Bure’s net asset value was SEK 10,591M compared to SEK 9,454M at the beginning of the year. · Total return on the Bure share was 47.9 per cent compared to the SIX Return Index that increased 20.7 per cent. · Consolidated profit after tax amounted to SEK 1,273M (1,132). Earnings per share amounted to SEK 18.46 (16.33). Second quarter 2019 · Net asset value

Tethys Oil’s holding of own shares has temporarily decreased below 5 percent

Tethys Oil AB (publ) (“Tethys Oil”) has, on 15 August 2019, entered into a share loan agreement (as the lender) regarding own shares with an investment bank. The purpose of the share loan is to facilitate the exercise of Tethys Oil’s long-term incentive programme of warrants from 2016. Following the entering of the share loan agreement, the number of own shares held by Tethys Oil has been reduced by 416,500 and the total number of own shares held amounts to 1,537,663. The holding corresponds to 4.28 percent of the total number of shares and votes in Tethys Oil (based on 35,896,310 shares

Endomines’ AB Half-year interim report for 2019: Rights issue successfully completed – production ramp-up at Friday commenced

Endomines AB, Stock Exchange Release 16 August 2019 at 08:30 CESTH1 2019 (vs. H1 2018)Operational highlights · Construction of the Mill was ongoing and developmental drifting at the Friday Mine was the focus for Q2 · Construction of the Tailings pond at the mill was also a large focus of time and materials · There was no gold concentrate production in Q2 2019 · LTIFR 11 (9) Financial highlights · Revenue was 3.5 MSEK (71.5) · EBITDA was -20.8 MSEK (0.0) · Total cash flow was -13.2 MSEK (71.6) · Earnings per share was -0.85 SEK (-0.10) Significant

Extraordinary general meeting

To the shareholders of Nustay A/S The board of directors hereby convenes an extraordinary general meeting of Nustay A/S, CVR no. 36 09 03 16, (the ”Company”), to be held on: Tuesday 3 September 2019 at 10:00 (CEST) at Gorrissen Federspiel Advokatpartnerselskab, Axeltorv 2, DK-1609 Copenhagen V, DenmarkAgenda 1. Authorisations to the board of directors to increase the share capital of the Company  1.a. Authorisation to the board of directors to increase the share capital at market price with pre-emption rights for existing shareholders 1.b. Authorisation to the board of

New pain organ discovered in the skin

Researchers at Karolinska Institutet in Sweden have discovered a new sensory receptor organ that is able to detect painful mechanical damage, such as pricks and impacts. The discovery is being published in the scientific journal Science.Pain causes suffering and results in substantial costs for society. Almost one person in every five experiences constant pain and there is a considerable need to find new painkilling drugs. However, sensitivity to pain is also required for survival and it has a protective function. It prompts reflex reactions that prevent damage to tissue, such as pulling

Fortum Loviisa power plant’s annual outage 2019 to begin

FORTUM CORPORATION PRESS RELEASE 16.8.2019 The annual outage of Fortum’s Loviisa nuclear power plant will begin with Unit 2 on Sunday, August 18th, followed by the servicing of Unit 1. This year, both units will undergo a refuelling outage. The annual outages are estimated to last a total of about 35 days. In addition to the normal periodic maintenance work and refuelling, tasks related to maintenance and continuous improvement, such as modification of the primary water purification system’s filtering, will be carried out on both units during the annual outage. This will result in

Humana reports second quarter results 2019

Improvement in Individual & Family and focus on growth in other business areasSecond quarter, April-June 2019  ·  Operating revenue was SEK 1,918m (1,696), an increase of 13%, of which organic growth was 2.5%.   ·  Operating profit was SEK 45m (78), a decrease of 42%. Excluding the effects of IFRS 16, the new standard for recognising leases that applies from 1 January 2019, and excluding acquisition expenses and revenues along with integration costs, operating profit amounted to SEK 65m (74), a decrease of 12%. The effects of IFRS 16 on operating profit amounted to SEK 10m (-).

Nordic Nanovector ASA: Invitation to Second Quarter and First Half 2019 Results Presentation and Webcast

Oslo, Norway, 16 August 2019 Nordic Nanovector ASA (OSE: NANO) announces that it will report its results for the second quarter and first half 2019 on Thursday, 22 August 2019. A presentation by Nordic Nanovector’s senior management team will take place at 8:30am CEST at: Thon Hotel Vika Atrium, Munkedamsveien 45, 0250 Oslo Meeting Room: AKER The presentation will be recorded as a webcast and will be available at www.nordicnanovector.com in the section: Investors & Media The results report and the presentation will be available at www.nordicnanovector.com in the section:

Interim report January-June 2019

This is information that Ratos AB is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact person set out above, at 08.00 CET on 16 August 2019. Ratos’s company portfolio is growing, but project write-downs impacted the result in the second quarter · Project write-downs in HENT had a negative impact of SEK -133m on earnings in the company portfolio · Net sales for the company portfolio amounted to SEK 7,096m (6,495), an organic increase of 9% · EBITA

IMPACT COATINGS AB (PUBL), INTERIM REPORT APRIL-JUNE 2019

FINANCIAL RESULTS SECOND QUARTER 2019 · Net revenue amounted to SEK 22 560 thousand (2 612) · Total income amounted to SEK 17 452 thousand (2 648) · Operating profit amounted to SEK -4 185 thousand (-13 527) · Operating profit after financial items amounted to SEK -4 191 thousand (-13 527) · Cash flow amounted to SEK -12 413 thousand (-11 698) · Equity-to-assets ratio amounted to 130% (284) · Order backlog at period end amounted to EUR 2 084 thousand FINANCIAL RESULTS JANUARY-JUNE 2019 · Net revenue amounted to SEK 25 507 thousand (9 055) · Total income

CapMan Real Estate invests in BREEAM certified office property in Leppävaara, Greater Helsinki

CapMan Real Estate press release          16 August 2019 9.00 a.m. EEST CapMan Real Estate invests in BREEAM certified office property in Leppävaara, Greater Helsinki CapMan Nordic Real Estate II fund has acquired Polaris Castor, a business park office building in Leppävaara, Greater Helsinki. Polaris Castor is a 6,000 sqm asset located in Leppävaara, one of the main office sub-markets in Greater Helsinki. The property is part of the Polaris Business Park and it is conveniently located by the Turunväylä motorway, 1.5km from the Leppävaara train station, 20 minutes from Helsinki-

Interim report January-June 2019

Q2 April-June 2019 · Net sales increased by 24 percent to SEK 1,776 (1,428) million · EBITDA increased to SEK 229 (114) million  · EBITA increased to SEK 129 (86) million · Organic EBITA growth was 3 percent · Profit after tax amounted to SEK 60 (61) million · Earnings per ordinary share after deduction of preference share dividends amounted to SEK 0.52 (0.54) Period January-June 2019 · Net sales increased by 19 percent to SEK 3,321 (2,783) million · EBITDA increased to SEK 365 (191) million · EBITA increased to SEK 166 (137) million · Organic EBITA

Volati convenes EGM to decide on so-called Leo transactions and withdrawal of ordinary shares

The Board of Volati AB has decided to convene an extraordinary general meeting on 30 September 2019 to consider proposals on transfers of shares to certain key personnel and withdrawal of the 1,000,000 ordinary shares held by the Company. The notice of the meeting and an announcement of the notice will be published in Post- och Inrikes Tidningar and Svenska Dagbladet in week 34 2019. * * * The English text is an unofficial translation of the Swedish original. In case of any discrepancies between the Swedish text and the English translation, the Swedish text shall prevail. NOTICE OF

Interim report, Q2 2019

Report period April – June, 2019 · Net sales in the quarter amounted to SEK 708 million (651), a growth of 8.6%. In constant currencies and adjusted for acquisitions, the organic growth was 2.4%. · EBITDA amounted to SEK 180 million (142), corresponding to an EBITDA margin of 25.4% (21.9). · EBITA amounted to SEK 120 million (108), corresponding to an EBITA margin of 17.0% (16.6). · Profit/loss for the quarter amounted to SEK 19 million (-27) and includes unrealized net foreign exchange differences of SEK -20 million (-48). · Cash flow from operating activities amounted to

Apetit Plc’s Half-Year Report 1 January – 30 June 2019: The Group’s result decreased due to the effects of the unusual grain crop of 2018 – Food Solutions’ result continued to develop favourably

Apetit Plc, Half-Year Financial Report, 16 August 2019 at 8:30 a.m.April–June 2019, continuing operations  · Net sales from continuing operations were EUR 64.5 (66.7) million · Operational EBITDA was EUR -1.2 (1.1) million · Operational EBIT was EUR -2.5 (0.1) million   January–June 2019, continuing operations  · Net sales from continuing operations were EUR 135.5 (120.5) million · Operational EBITDA was EUR 0.9 (2.0) million · Operational EBIT was EUR -1.7 (0.0) million   April–June 2019, the Group, including discontinued operations*  · Consolidated net

BJÖRN BORG AB INTERIM REPORT JANUARY – JUNE 2019

APRIL 1 – JUNE 30, 2019       · The Group’s net sales increased 1.0 percent to SEK 141.7 million (140.3). Excluding currency effects, sales fell 2.2 percent. · Net sales for own e-commerce and to e-tailers amounted to SEK 32.1 million (31.0), an increase of 3.5 percent. · The gross profit margin was 55.4 percent (59.9). · The operating loss was SEK 1.7 million (+2.9). · The loss after tax amounted to SEK 2.3 million (+1.5). · Earnings per share before and after dilution amounted to SEK –0.09 (0.06). JANUARY 1 – JUNE 30, 2019  · The Group’s net sales increased 6.6

Sunnybrook Health Sciences Centre treats its first patient with Elekta Unity MR-Linac

Clinical implementation of breakthrough technology that Sunnybrook scientists and physicians helped transform from concept to clinical practiceTORONTO, August 16, 2019 – Elekta (EKTA-B.ST) today announced that the Odette Cancer Centre at Sunnybrook Health Sciences Centre has treated its first patient using Elekta Unity, a transformative magnetic resonance radiation therapy (MR/RT) system that enables personalized precision radiation therapy. Elekta Unity combines a state-of-the-art 1.5T MRI scanner, a best-in-class 7 MV linear accelerator and breakthrough real-time adaptive radiotherapy

Apetit Group’s updated comparison data

Apetit Plc, Stock Exchange Release 16.8.2019 at 8.25 a.m.On 10 July 2019, Apetit announced that it has agreed to sell its fresh cut products business, part of the Food Solutions segment to the Swedish company Greenfood AB. The transaction is expected to be completed in the second half of 2019. To be completed, the transaction requires the approval of the competition authorities. As a result of the agreement, Apetit reports the sold business operations as a discontinued operation. In addition to Fresh Cut Foods, discontinued operations include the Seafood segment. The Seafood segment is

There are no items matching the current filter
There are no more items matching the current filter
Back to top